Press release
Cancer Biomarkers Market is Expected to Grow at a CAGR of 9.9% between 2022 and 2031, Reaching US$ 31.4ย Billion | Exclusive Report by Transparency Market Research
Cancer Biomarkers
Cancer biomarkers are crucial for early cancer detection and personalized treatment strategies. Factors such as increasing cancer prevalence, a growing elderly population, and advancements in biomarker technology are anticipated to fuel market expansion. Additionally, the utilization of CEA and HER2 biomarkers for detecting various cancers including breast, thyroid, and small cell lung cancer is expected to drive market growth. Major industry players are actively engaging in research and development endeavors to capitalize on the promising opportunities within the global cancer biomarkers market.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ :
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=479&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR
๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐๐ซ๐จ๐๐ข๐ฅ๐๐:
F. Hoffmann-LA Roche Ltd.,Thermo Fisher Scientific, Inc.,Merck & Co, Inc.,Abbott Laboratories,Bristol-Myers Squibb Company,PerkinElmer, Inc.,Qiagen N.V.,Siemens AG,Exact Sciences Corporation,Novartis AG,Bio-Rad Laboratories,Illumina,Agilent Technologies Inc.,Hologic, Inc.,bioMรฉrieux SA
๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง:
๐๐ฒ๐ฉ๐
Protein
Genetic
Others
๐๐ฒ๐ฉ๐ ๐จ๐ ๐๐๐ง๐๐๐ซ
Lung
Breast
Leukemia
Melanoma
Colorectal
Prostate
Ovarian
Liver
Others
๐๐ซ๐จ๐๐ข๐ฅ๐ข๐ง๐ ๐๐๐๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ
Omics
Imaging
Immunoassay
Bioinformatics
Others
๐๐ฉ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง
Diagnostics
R&D
Prognostics
Others
๐๐๐ฒ ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ฆ๐๐ง๐ญ๐ฌ:
Inย January 2022, a University of Oxford study published in the Clinical Cancer Research Journal defined a new type of blood test that can be used to detect a range of cancers and their spread throughout the body. The study had a sample size of 300 patients, with non-specific but concerning symptoms of cancer such as fatigue and weight loss. According to the study, cancer was correctly detected in 19 out of every 20 patients that used the test. In those with cancer, metastatic disease was identified with an overall accuracy of 94%.
Inย June 2021, Hill's Pet Nutrition announced plans to invest more than US$ 250 Mn in building a new factory in Leavenworth County in its home state of Kansas in order to cater to the rise in demand for its pet nutrition supplements
Inย December 2020, the FDA approved Thermo Fisher Scientific's NGS-based companion diagnostic for EGFR Exon20 insertion mutant to help identify non-small cell lung cancer tumor tissue
๐๐ฅ๐๐๐ ๐๐ง ๐๐ซ๐๐๐ซ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.transparencymarketresearch.com/checkout.php?rep_id=479
๐๐๐จ๐ฎ๐ญ ๐๐ซ๐๐ง๐ฌ๐ฉ๐๐ซ๐๐ง๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก
Transparency Market Research, a globalย market research companyย registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
๐๐จ๐ง๐ญ๐๐๐ญ:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website:ย https://www.transparencymarketresearch.comย ย ย ย ย ย
Email:ย sales@transparencymarketresearch.com
Follow Us:ย LinkedIn|ย Twitter|ย Blogย |ย YouTube
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Biomarkers Market is Expected to Grow at a CAGR of 9.9% between 2022 and 2031, Reaching US$ 31.4ย Billion | Exclusive Report by Transparency Market Research here
News-ID: 3400997 • Views: โฆ
More Releases from Transparency Market Research
Global Opioid Induced Constipation Treatment Market Set to Reach USD 5.2 Billion โฆ
The global opioid induced constipation (OIC) treatment market is witnessing steady and sustained growth as healthcare systems worldwide place increasing emphasis on comprehensive pain management and supportive care. Valued at US$ 2.9 billion in 2025, the market is projected to reach US$ 5.2 billion by 2036, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2036. Growth is primarily fueled by the rising prevalence of chronicโฆ
Pneumatic Flux Chipper Market Expanding at 7.4% CAGR Through 2036 - By Product T โฆ
The global Pneumatic Flux Chipper Market is set to witness sustained and resilient growth over the next decade, underpinned by expanding heavy manufacturing activities, rising welding and fabrication demand, and continuous investments in industrial infrastructure across emerging and developed economies. According to the latest industry analysis, the market was valued at US$ 760.5 Mn in 2025 and is projected to reach US$ 1,680.8 Mn by 2036, expanding at a compoundโฆ
AI in Automotive Market Outlook 2036: Global Industry to Surge from US$ 19.8 Bil โฆ
The AI in automotive market is entering a phase of exponential expansion, supported by rapid digitization of vehicles, growing safety mandates, and consumer demand for intelligent mobility. The global market was valued at US$ 19.8 Bn in 2025 and is projected to reach US$ 244.4 Bn by 2036, registering a remarkable CAGR of 27% from 2026 to 2036.
This growth trajectory reflects the transition of automobiles from mechanically driven products toโฆ
Hypodermic Needles Market to Reach US$ 7.9 Billion by 2036 on Rising Injectable โฆ
The global hypodermic needles market was valued at approximately US$ 4.2 billion in 2025 and is projected to reach around US$ 7.9 billion by 2036, expanding at a CAGR of nearly 5.8% from 2026 to 2036, driven by the rising prevalence of diabetes, cancer, and chronic diseases, growing demand for injectable drugs and biologics, and the expansion of global vaccination and immunization programs; increasing adoption of safety-engineered and disposable needles,โฆ
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by โฆ
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emergingโฆ
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio โฆ
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boostโฆ
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne โฆ
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of theโฆ
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve โฆ
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:โฆ
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance โฆ
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launchโฆ
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung โฆ
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. Forโฆ
